104 related articles for article (PubMed ID: 12724721)
1. Systemic side effects of topical latanoprost.
Rajan MS; Syam P; Liu C
Eye (Lond); 2003 Apr; 17(3):442-4. PubMed ID: 12724721
[No Abstract] [Full Text] [Related]
2. [Latanoprost (Xalatan) and a systemic respiratory effect? Apropos of a case].
Veyrac G; Chiffoleau A; Cellerin L; Larousse C; Bourin M
Therapie; 1999; 54(4):494-6. PubMed ID: 10667120
[No Abstract] [Full Text] [Related]
3. Allergic contact dermatitis caused by topical eye drops.
Spaeth GL
Am J Ophthalmol; 2006 Oct; 142(4):706. PubMed ID: 17011880
[No Abstract] [Full Text] [Related]
4. Latanoprost and periocular skin color changes.
Wand M; Ritch R; Isbey EK; Zimmerman TJ
Arch Ophthalmol; 2001 Apr; 119(4):614-5. PubMed ID: 11296032
[No Abstract] [Full Text] [Related]
5. Evaluation of the additive effect of bunazosin on latanoprost in primary open-angle glaucoma.
Maruyama K; Shirato S; Haneda M
Jpn J Ophthalmol; 2005; 49(1):61-2. PubMed ID: 15692779
[No Abstract] [Full Text] [Related]
6. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
[TBL] [Abstract][Full Text] [Related]
7. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
[TBL] [Abstract][Full Text] [Related]
8. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.
Konstas AG; Katsimbris JM; Lallos N; Boukaras GP; Jenkins JN; Stewart WC
Ophthalmology; 2005 Feb; 112(2):262-6. PubMed ID: 15691561
[TBL] [Abstract][Full Text] [Related]
9. Side effects associated with prostaglandin analog therapy.
Alm A; Grierson I; Shields MB
Surv Ophthalmol; 2008 Nov; 53 Suppl1():S93-105. PubMed ID: 19038628
[TBL] [Abstract][Full Text] [Related]
10. Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes.
Chou SY; Chou CK; Kuang TM; Hsu WM
Eye (Lond); 2005 Jul; 19(7):784-7. PubMed ID: 15359238
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of brimonidine, dorzolamide and latanoprost as adjunctive therapy in primary open angle glaucoma.
Sodhi PK; Pandey RM; Ratan SK
Int J Clin Pract; 2003 Dec; 57(10):875-8. PubMed ID: 14712889
[TBL] [Abstract][Full Text] [Related]
12. Bilateral poliosis and granulomatous anterior uveitis associated with latanoprost use and apparent hypotrichosis on its withdrawal.
Waheed K; Laganowski H
Eye (Lond); 2001 Jun; 15(Pt 3):347-9. PubMed ID: 11450742
[No Abstract] [Full Text] [Related]
13. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
[TBL] [Abstract][Full Text] [Related]
14. Topical prostaglandin F(2alpha) analog induced poliosis.
Chen CS; Wells J; Craig JE
Am J Ophthalmol; 2004 May; 137(5):965-6. PubMed ID: 15126178
[TBL] [Abstract][Full Text] [Related]
15. Heart block following topical latanoprost treatment.
De Smit E; Theodorou M; Hildebrand GD; Bloom P
BMJ Case Rep; 2011 Oct; 2011():. PubMed ID: 22679164
[TBL] [Abstract][Full Text] [Related]
16. Severe hypotony following cataract extraction in a patient on latanoprost.
Wu G; Morrell A
Eye (Lond); 2000 Dec; 14(Pt 6):915-6. PubMed ID: 11584861
[No Abstract] [Full Text] [Related]
17. Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops.
Flórez A; Rosón E; Conde A; González B; García-Doval I; de la Torre C; Cruces M
J Am Acad Dermatol; 2005 Nov; 53(5):909-11. PubMed ID: 16243161
[No Abstract] [Full Text] [Related]
18. Transient monocular visual loss following administration of topical latanoprost: a case report.
Luu ST; Lee AW; Chen CS
Can J Ophthalmol; 2009 Dec; 44(6):715. PubMed ID: 20029498
[No Abstract] [Full Text] [Related]
19. Herpes simplex dendritic keratitis after treatment with latanoprost for primary open angle glaucoma.
Ekatomatis P
Br J Ophthalmol; 2001 Aug; 85(8):1008-9. PubMed ID: 11501520
[No Abstract] [Full Text] [Related]
20. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension.
Chiba T; Kashiwagi K; Chiba N; Tsukahara S
Br J Ophthalmol; 2006 Mar; 90(3):314-7. PubMed ID: 16488953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
